Repository logo
 

Specificity of RNAi, LNA and CRISPRi as loss-of-function methods in transcriptional analysis

Published version
Peer-reviewed

Type

Article

Change log

Authors

Mangei, Jasmin 
Mascalchi, Patrice 
Quarantotti, Valentina  ORCID logo  https://orcid.org/0000-0003-4544-9939

Abstract

ABSTRACT

Loss-of-function (LOF) methods, such as RNA interference (RNAi), antisense oligonucleotides or CRISPR-based genome editing, provide unparalleled power for studying the biological function of genes of interest. When coupled with transcriptomic analyses, LOF methods allow researchers to dissect networks of transcriptional regulation. However, a major concern is nonspecific targeting, which involves depletion of transcripts other than those intended. The off-target effects of each of these common LOF methods have yet to be compared at the whole-transcriptome level. Here, we systematically and experimentally compared non-specific activity of RNAi, antisense oligonucleotides and CRISPR interference (CRISPRi). All three methods yielded non-negligible offtarget effects in gene expression, with CRISPRi exhibiting clonal variation in the transcriptional profile. As an illustrative example, we evaluated the performance of each method for deciphering the role of a long noncoding RNA (lncRNA) with unknown function. Although all LOF methods reduced expression of the candidate lncRNA, each method yielded different sets of differentially expressed genes upon knockdown as well as a different cellular phenotype. Therefore, to definitively confirm the functional role of a transcriptional regulator, we recommend the simultaneous use of at least two different LOF methods and the inclusion of multiple, specifically designed negative controls.

Description

Keywords

31 Biological Sciences, 3102 Bioinformatics and Computational Biology, 3105 Genetics, Genetics, Human Genome, Biotechnology, Generic health relevance

Journal Title

Conference Name

Journal ISSN

Volume Title

Publisher

Cold Spring Harbor Laboratory
Sponsorship
Cancer Research UK (CB4180)
Cancer Research UK (C14303/A17197)
Cancer Research UK (20412)
Wellcome Trust (202878/Z/16/Z)
European Research Council (615584)